Meenaakshi Molecules

Founded: 2010 • Age: 16 yrs
Pharmaceutical manufacturing, importing, and exporting of APIs, intermediates, veterinary products, and cosmetics in India.

About Meenaakshi Molecules

Meenaakshi Molecules is a Healthcare company founded in 2010. Pharmaceutical manufacturing, importing, and exporting of APIs, intermediates, veterinary products, and cosmetics in India. Its Indian entity Meenaakshi Molecules Private Limited reported revenue of β‚Ή10.44 Cr. Meenaakshi Molecules offers products and services including APIs and Intermediates. Its focus areas include Pharmaceuticals, API Manufacturing, Chemical Intermediates and Veterinary.

Company details

Meenaakshi Molecules is recognized as a manufacturer and importer-exporter headquartered in Hyderabad, India, with over two decades of experience in the pharmaceutical industry. A diverse portfolio including Active Pharmaceutical Ingredients, intermediates, pellets, veterinary products, and cosmetics is maintained, alongside commitments to quality and regulatory compliance. Innovation and customer needs are addressed through comprehensive Research and Development services, contributing to solutions in an evolving pharmaceutical landscape, while fostering reliability for global clients.

  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website meenaakshi.in
  • Social LinkedIn Instagram
  • Legal Name Meenaakshi Molecules Pvt. Ltd
  • Date of Incorporation 02 Jan, 2014
  • Jurisdiction Secunderabad, Telangana, India
Key Metrics
  • Indian entity revenue
    ₹10.44 Cr

    FY 2025 · -61% YoY

  • Indian entity net profit
    ₹10.1 Lakh

    FY 2025 · 1% margin

  • Indian entity EBITDA
    ₹64.7 Lakh

    FY 2025 · 6% margin

Products & Services of Meenaakshi Molecules

Meenaakshi Molecules offers a comprehensive portfolio of products and services, including APIs and Intermediates.

APIs
Pharmaceutical Products

Active Pharmaceutical Ingredients are manufactured and exported for therapeutic uses such as anticancer and antidiabetic treatments.

Intermediates
Chemical Intermediates

Chemical intermediates are produced for the synthesis of APIs and other pharmaceutical compounds.

Board of directors of Meenaakshi Molecules Private Limited (Meenaakshi Molecules)

Meenaakshi Molecules Private Limited is the primary company behind Meenaakshi Molecules. The board of Meenaakshi Molecules Private Limited currently have 2 directors; the longest-serving is Anjaiah Venkamasetty, appointed in 2014. 4 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Anjaiah Venkamasetty
DIN 06747951
Managing Director02 Jan 201412 yrs 10 moMeenaakshi Molecules Private Limited
Madhavi Venkamasetty
DIN 06750135
Whole-time director02 Jan 201412 yrs 10 moMeenaakshi Molecules Private Limited

Financials of Meenaakshi Molecules

Figures of Meenaakshi Molecules Private Limited, the primary company behind Meenaakshi Molecules, for FY 2025. Revenue was ₹10.44 Cr (-61% year on year). Net profit was ₹10.1 Lakh (1% margin). EBITDA was ₹64.7 Lakh (6% margin). Revenue has grown at a compounded annual rate of +32% over three years and +14% over five years.

  • ₹10.44 CrRevenue · FY 2025 · -61% YoY
  • ₹10.1 LakhNet profit · 1% margin
  • ₹64.7 LakhEBITDA · 6% margin
  • ₹5 LakhPaid-up capital
  • +32%Revenue CAGR, 3 years
  • +14%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Meenaakshi Molecules Private Limited are on its company page.

Premium access

Detailed financial statements for Meenaakshi Molecules

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Meenaakshi Molecules

Meenaakshi Molecules was founded in 2010.

The primary company behind Meenaakshi Molecules, Meenaakshi Molecules Private Limited, reported revenue of β‚Ή10.44 Cr for FY 2025, down 61% year on year.

Meenaakshi Molecules is recognized as a manufacturer and importer-exporter headquartered in Hyderabad, India, with over two decades of experience in the pharmaceutical industry. A diverse portfolio including Active Pharmaceutical Ingredients, intermediates, pellets, veterinary products, and cosmetics is maintained, alongside commitments to quality and regulatory compliance. Innovation and customer needs are addressed through comprehensive Research and Development services, contributing to solutions in an evolving pharmaceutical landscape, while fostering reliability for global clients.

Meenaakshi Molecules offers APIs and Intermediates.

Meenaakshi Molecules operates through Meenaakshi Molecules Private Limited.

The legal entities of Meenaakshi Molecules currently have 2 directors, including Anjaiah Venkamasetty, Madhavi Venkamasetty.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available